Home / Inspections / 1164463

FDA Inspection 1164463 — Blood Bank Of Delmarva A Division Of New York Blood Center

Blood Bank Of Delmarva A Division Of New York Blood Center — FEI 3019199602

The FDA completed an inspection of Blood Bank Of Delmarva A Division Of New York Blood Center on Dec 21, 2021 in Dagsboro, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 21, 2021
Fiscal Year
2022
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dagsboro, DE (United States)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.